Clinical trial
A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip Arthroplasty
NCT01285024 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip Arthroplasty
- Lead sponsor
- The Cleveland Clinic
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2010
- Completion date
- December 31, 2014
- Enrollment
- 109 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.